Business
Helix Biopharma to Present at the Rodman & Renshaw 11th Annual Healthcare Conference
AURORA, Ontario, Sept. 3 /CNW/ -- Helix BioPharma Corp. (TSX, FSE: "HBP" / OTCQX: "HXBPF") today ...
About this update from Helix Biopharma Corp.
[{"type":"text","content":"\n\n\n\nAURORA, Ontario, Sept. 3 /CNW/ -- Helix BioPharma Corp. (TSX, FSE: "HBP"\n/ OTCQX: "HXBPF") today announced that John Docherty, president and chief\noperating officer, will present at the Rodman and Renshaw 11th Annual\nHealthcare Conference at 12:05 p.m. EDT on Wednesday, Sept. 9, at the New York\nPalace Hotel in New York. Mr. Docherty will provide an overview of the\nCompany's leading product development programs L-DOS47 and Topical Interferon\nAlpha-2b. The slide show portion of the presentation will be posted on the\nCompany's website, www.helixbiopharma.com, on September 9th, 2009.\n\n\n\nAbout Helix BioPharma Corp.\n\n\nHelix BioPharma Corp. is a biopharmaceutical company specializing in the\nfield of cancer therapy. The Company is actively developing innovative\nproducts for the prevention and treatment of cancer based on its proprietary\ntechnologies. Helix's product development initiatives include its novel\nL-DOS47 new drug candidate and its Topical Interferon Alpha-2b. Helix is\nlisted on the TSX and FSE under the symbol "HBP" and on the OTCQX\nInternational Market under the symbol "HXBPF".\n\n\n\nFor further information contact:\n\n\n\nInvestor & Media Relations\nRobert Flamm, Ph.D. Ian Stone\nRusso Partners LLC Russo Partners LLC\nTel: (212) 845-4226 Tel: (619) 814-3510\nEmail: [email protected] Fax: (619) 955-5318\nwww.russopartnersllc.com Email:\n [email protected]\n\n\n\nThis News Release contains certain forward-looking statements regarding\nthe Company's planned presentation at the Rodman & Renshaw 11th Annual\nHealthcare Conference and the Company's research and development initiatives,\nwhich statements can be identified by the use of forward looking terminology\nsuch as "will", "developing", "September 9", or comparable terminology\nreferring to future events or results. Forward looking statements are\nstatements about the future and are inherently uncertain, and Helix's actual\nresults could differ materially from those anticipated in these\nforward-looking statements as a result of numerous factors, including without\nlimitation, the fact that the Rodman & Renshaw presentation and the posting of\nthe slide show portion of the presentation on the Company's website are\nsubject to change or ...